首页|基于TGF-β1/CD147信号探讨慢性束缚应激促小鼠乳腺癌进展及逍遥散调节机制研究

基于TGF-β1/CD147信号探讨慢性束缚应激促小鼠乳腺癌进展及逍遥散调节机制研究

扫码查看
目的 基于TGF-β1/CD147信号探讨慢性束缚应激促小鼠乳腺癌进展及逍遥散调节机制。方法 40只BABL/c小鼠随机分为移植瘤组(Tumor)、模型组(Model)、逍遥散组(Xiaoyaosan)和米非司酮组(Mifepristone),将4T1细胞株接种于各组小鼠腋下,待成瘤后,除Tumor组外其余各组小鼠均进行慢性束缚应激21天,同时Xiaoyaosan组和Mifepristone组小鼠给予相对应的药物灌胃,Tumor组和Model组小鼠灌胃生理盐水。造模结束后,小鼠麻醉断头处死,测量小鼠瘤体重量和体积、内脏指数;采用ELISA方法检测各组小鼠血清肿瘤标志物糖类抗原ca199(Carbohydrate antigen199,CA199)、癌胚抗原(Carcino-embryonic antigen,CEA)、血管内皮生长因子(Vascular endothelial growth factor,VEGF)的含量,血清多巴胺(Dopamine,DA)和皮质酮(Corticosterone,CORT)的含量,以及肿瘤组织转化生长因子β1(Transforming growth factor-β1,TGF-β1)和白介素10(Interleukin 10,IL-10)的含量。采用免疫组化和Western blot方法检测各组小鼠肿瘤组织巨噬细胞极化标志物诱导型一氧化氮合酶(Inducible nitric oxide synthase,iNOS)和精氨酸酶 1(Arginase-1,Arg-1)的表达,以及肿瘤组织中细胞外基质金属蛋白酶诱导剂(Extracellular matrix metalloproteinase inducer,EMMPRIN,CD147)及其下游信号分子基质金属蛋白酶2(Matrix metalloproteinases 2,MMP2、基质金属蛋白酶9(MMP9)和VEGF的表达。结果 与Tumor组比较,Model组小鼠肿瘤重量和体积,血清CA199、CEA、VEGF、CORT含量,肿瘤TGF-β1和IL-10含量均显著增加;内脏指数和血清DA含量显著减少;肿瘤巨噬细胞M2型极化标志物Arg-1的表达显著增加,M1型极化标志物iNOS的表达显著降低;肿瘤CD147及其下游信号分子MMP2、MMP9和VEGF蛋白表达显著增加,逍遥散和米非司酮均可有效逆转以上改变。结论 慢性束缚应激促小鼠乳腺癌进展的机制与肿瘤相关巨噬细胞M2型极化释放TGF-β1增加、激活CD147及其下游相关信号有关,而逍遥散可缓解应激条件下皮质酮增高引起的巨噬细胞M2型极化,减少TGF-β1的生成,抑制CD147及其下游信号,从而抑制慢性应激引起的小鼠乳腺癌进展。
To Investigate the Progression Mechanism of Breast Cancer in Mice Induced by Chronic Restraint Stress and the Regulatory Mechanism of Xiaoyaosan Based on TGF-β1/CD147 Signal
Objective To investigate the progression of breast cancer in mice induced by chronic binding stress and the regulatory mechanism of Xiaoyao SAN based on TGF-β1/CD147 signal pathway.Methods 40 BABL/c mice were randomly divided into tumor group,model group,Xiaoyaosan group and Mifepristone group,and then 4T1 cell line was inoculated into the armpits of each group of mice.After Tumor formation,mice in all groups except tumor group were subjected to chronic restraint stress for 21 days.Meanwhile,mice in Xiaoyaosan and Mifepristone groups were gavaged with the corresponding drugs,and mice in the other two groups were gavaged with normal saline.After the modeling,the mice were sacrificed after anaesthesia.The weight and volume of the tumors and visceral index of the mice were measured.The contents of serum tumor markers(CA199,CEA,VEGF),serum neurotransmitters(DA and CORT),and inflammatory mediators(TGF-β1 and IL-10)in tumor tissues were detected by Elisa.The expressions of iNOS and Arg-1,the polarization markers of macrophages,and the expressions of CD147 and its downstream signaling molecules MMP2,MMP9 and VEGF in tumor tissues were all detected by immunohistochemistry and Western blot.Results Compared with tumor group,in model group,tumor weight and volume,serum CA199,CEA,VEGF,CORT content,tumor TGF-β1 and IL-10 content were significantly increased;visceral index and serum DA content were significantly reduced;the expression of M2-type polarization marker Arg-1 in tumor macrophages was significantly increased,while the expression of M1-type polarization marker iNOS was significantly decreased;the expressions of CD147 and its downstream signaling molecules MMP2,MMP9 and VEGF were significantly increased.Both Xiaoyaosan and mifepristone could effectively reverse the above changes.Conclusion The mechanism of chronic restraint stress promoting breast cancer progression in mice is related to the increased release of TGF-β1 from M2-type polarization of tumor-associated macrophages,which activates CD147 and its downstream related signals.Xiaoyaosan could relieve the M2-type polarization of macrophages caused by increased corticosterone under stress conditions,reduce the production of TGF-β1,inhibit CD147 and its downstream signal,and thus inhibit the progression of breast cancer caused by chronic restraint stress in mice.

Chronic restraint stressBreast cancerTumor-bearing miceXiaoyaosanTGF-β1/CD147 signal

刘燕、刘高源、彭梦薇、匡洛逸、罗紫龙、杨铁柱、吴耀松、陈玉龙

展开 >

河南中医药大学中医学院\仲景学院 郑州 450046

河南省洛阳正骨医院\河南省骨科医院 郑州 450000

慢性束缚应激 乳腺癌 荷瘤小鼠 逍遥散 TGF-β1/CD147信号

国家自然科学基金委员会青年基金河南省科技厅河南省重点研发与推广专项(科技攻关)河南中医药大学河南省"双一流"创建学科中医学科学研究专项

82104717232102310443HSRP-DFCTCM-2023-1-11

2024

世界科学技术-中医药现代化
中科院科技政策与管理科学研究所,中国高技术产业发展促进会

世界科学技术-中医药现代化

CSTPCD北大核心
影响因子:1.175
ISSN:1674-3849
年,卷(期):2024.26(4)
  • 6